Hi,
this looks pretty comprehensive.
Below is the list of speakers:
M. Scott Marshall (The W3C consortium). Where is the W3C now and what
should
happen next?
Phil Brooks (Eli Lilly), Semantic Web for Health Care and Life Sciences
(Tutorial)
Lee Harland (Pfizer) Industry needs
Derek Scuffell (Syngenta) Opportunities and minimum requirements for
industry
Phil Ashworth (UCB) Industrial Strength Architectures for life sciences,
including considerations for federated search.
Don Jennings (Eli Lilly) Experience of TopBraid, Integrating semantic
access
to data within Lilly and building linked data maps
Laurent Alquier (J&J) Intranet data integration using Semantic MediaWiki
Nicolas Le Novère (EMBL-EBI), the Importance of Semantics to Systems
Biology
Dietrich Rebholz-Schuhmann (EMBL-EBI) Practical experiences from the SESL
(Semantic Enhancement of the Scientific Literature) project.
Jerven Bolleman (SIB) Quality control using sparql and UniProt rdf
Jeremy Frey (U. Southampton) Practical applications of semantic web
technology in Chemistry.
Dean Allemang Examples of best practice from industry
Michel Dumontier (Carleton University) Bio2RDF
Matthias Samwald, (Medical University of Vienna), title TBC
=> 50 Attendees sounds right.
=> There has been some room for break-out sessions and the definition of
business needs / challenges
=> The workshop serves as one source of input to define the EBI's stand
on
Semantic Web technology (past, present, future)
=> The IP workshop was followed by a two-day tutorial on Linked Data /
Ontologies / Semantic resources (Slides will be available soon)
Concerning Scott's email: there are a couple of resources (Triple Stores)
under development at the EBI, which are or will be available as public
resources and which distribute data of different kinds:
* SPARQL endpoints (UniProt, SESL, possibly ChEMBL)
* Triple Stores for download:
*** UniProt
*** SESL: Diabetes driven data integration, incl. ArrayExpress, UniProt,
publisher data, in preparation
*** CALBC: several 100k Medline abstracts with a large number of
annotations, genes/proteins, diseases, chemical entities, species, all
about
immunology
Stay tuned,
-drs-
On 25/05/2011 11:57, LeeH wrote:
I didnt see these questions get answered so...
- The workshop was organised by me (Lee Harland, Pfizer), Derek Scuffle
(Syngenta), Dominc Clark& Nicolas Le Novere.
- There were about 50 people there, mostly industry and some invited
speakers& some EBI
- For those who dont know it, the EBI industry programme is a
subscription-based group that provides a mechanism for life science
industry
to work directly with the EBI on strategy and addressing needs. The
workshop
was part of a large series of workshops we run on many different topics
relevant to industry (google ebi industry programme for more info). The
aim
of this was to allow industry to chat about its experience with SW in an
informal setting, away from the pressure of big conferences, and to
explore
areas of collaboration with the EBI
- There were no biotech representatives there; the EBI also runs an SME
forum which provides a similar mechanism for EBI& biotech to get
together.
I dont know much more than this, but if interested Dominic Clark is your
man.
- Access to the presentations. I was going to speak to dominic about this
next week. Generally presentations are stored in a secure website, which
allows presenters (especially from companies) to be sure their materials
are
not generally distributed. However, i think many presenters whould be OK
with this, so we will see what we can do...
- Finally, is this related to the Pistoia alliance.... The direct answer
is
no. The EBI industry programme is a completely separate entity and this
was
purely based on that. However, a significant number of folks who are
active
in Pistoia (such as me) have also worked long term with the EBI. the EBI
is
also a member of Pistoia too. So, i think the best thing to say is that
"there are great connections between the 2 groups". Also the EBI is the
lead
on the Pistoia SESL project (semantic enrichement of the scientific
literature - more details are available to those interested), so there
are
firm connections between ebi& pistoia in the semantic area
I think that answers all the questions I've seen.... Happy to talk to
anyone
about thoughts/opportunities etc. Within Pistoia we're actively
discussing
where the semantic web fits, to that end there's an interesting meeting
coming up
http://www.pistoiaalliance.org/2011-Events/6-june-2011-pistoia-alliance-technical-committee-open-teleconference-and-webinar.html
Lee
On 25 May 2011 09:17, Erick Antezana<erick.antez...@gmail.com> wrote:
are the presentations/program somewhere available?
was there any representative of a biotech company attending such
workshop?
is it somehow related to the Pistoia Alliance?
cheers,
Erick
On 25 May 2011 00:56, M. Scott Marshall<mscottmarsh...@gmail.com> wrote:
Last week, Michel Dumontier, Matthias Samwald and I were invited to
speak at the EBI Semantic Web Industry Workshop. We each gave some
HCLS perspectives and heard many other very interesting talks from
industry representatives. Phil Brooks (Johnson& Johnson) gave an
excellent tutorial. TopBraid Composer was widely touted. A few
encouraging news items: Nicolas Le Novere told us that MIRIAM
identifiers will go to URIs (from URNs) and Jerven Bolleman told us
that Uniprot is getting a SPARQL endpoint for their RDF. There was a
strong pharma presence at the workshop.
Also, on the LODD front:
* Oktie Hassanzadeh has created a linkedct (linked version of
clinicaltrials.gov) that is updated nightly
* Anja Jentzsch is working on an update of several Berlin-hosted LODD
data
sets
* Egon Willighagen is updating the downloadable RDF version of ChEMBL
to version 9
Cheers,
Scott
--
M. Scott Marshall, W3C HCLS IG co-chair, http://www.w3.org/blog/hcls
http://staff.science.uva.nl/~marshall
--
Dietrich Rebholz-Schuhmann, MD, PhD - Research Group Leader
EBI, Wellcome Trust Genome Campus, Hinxton CB10 1SD (UK)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - -
TM support:www.ebi.ac.uk/Rebholz-svr | tm-supp...@ebi.ac.uk
